HormonesRadiofrequency Therapy for Menopausal Vaginal Tissue Shows Only Non-Significant Trends in Small Pilot
Genitourinary syndrome of menopause (GSM) is caused by falling estrogen, which thins the vaginal lining, reduces collagen and elasticity, and leads to dryness, painful sex and urinary problems. Microablative fractional radiofrequency delivers controlled heat to create tiny zones of injury, intended to trigger tissue remodeling and new collagen. A pilot study from Brazil looked at vaginal tissue samples from 14 postmenopausal women with GSM after treatment. Researchers saw a trend toward thicker vaginal epithelium and larger stromal collagen fibers, but responses varied widely and neither change reached statistical significance. The study was not designed to show clinical benefit, and it did not report symptoms. It offers an early look at tissue-level response, but larger controlled studies are needed to confirm any effect and to identify which women, if any, respond best.